Ad
related to: Novavax
Search results
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 4 days agoOther vaccine stocks are climbing as well. Shares of CureVac which, like Moderna, develops messenger...
10 Best Growing Industries To Invest in for 2024
GoBankingRates via AOL· 11 hours agoThe global biotechnology market size is forecasted to reach $3.88 trillion by 2030, representing a CAGR of 13.96%. Some of the best companies to invest...
Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks
The Wall Street Journal· 3 days agoModerna, BioNTech, CureVac and Novavax have added billions of dollars in combined market...
Bird Flu Cases Spur Retail Trader Rush Into Vaccine Stocks
Bloomberg via Yahoo Finance· 4 days ago(Bloomberg) -- Mounting cases of bird flu in humans is luring the day trading crowd to snap up stock...
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb - Moderna (NASDAQ:MRNA)
Benzinga· 4 days agoAccording to a report from NBC News, experts predict a small rise in COVID-19 cases as a newly...
3 Biotech Stocks to Buy Now: May 2024
InvestorPlace· 4 days agoWhile it tends to fly under the radar for many people, the biotech industry has seen a resurgence in investor interest over the last couple of years....
Biz: Club at Atlantic Beach builds for new era; Raleigh restaurant asks for help - Triangle Business...
The Business Journals· 2 days agoBeachgoers to Atlantic Beach this Memorial Day weekend will see that an ocean-front club that has...
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks via Yahoo Finance· 3 days agoThe Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE)...
Explainer-What Are the FLiRT COVID Variants and Are They More Contagious?
US News & World Report· 3 days agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus' spike protein. One of them, called KP.2, has become the most commonly circulating variant ...
Pfizer plans to cut costs by $1.5 billion as demand for COVID vaccine dwindles
Quartz· 4 days agoPharma giant Pfizer announced Wednesday another cost-cutting initiative as the company struggles...
